Why did RGT.AX stock spike in volume pre-market today?

The spike to **4,495,188.00** shares reflects sudden trader interest, likely linked to pipeline speculation or thin-book liquidity. Clinical-stage updates or broker attention can trigger such moves; verify company announcements and volume persistence before trading.

What are the immediate technical levels to watch for RGT.AX stock?

Watch **A$0.059** support and **A$0.08** short-term resistance. A sustained break above **A$0.10** would be bullish; stops belong below **A$0.058** due to volatility and low float.

How does Meyka AI view RGT.AX stock from a valuation perspective?

Meyka AI assigns a **B (61.14/100, HOLD)** grade, noting high price-to-sales **8.58** and limited revenues. The firm flags cash constraints and clinical risk as valuation headwinds.

What is Meyka AI's price forecast for RGT.AX stock?

Meyka AI's forecast model projects **A$0.12** in 12 months, implying **100.00%** upside from **A$0.06**. Forecasts are model projections and not guarantees; they depend on trial progress and funding.

AU Stocks

RGT.AX Argent BioPharma ASX pre-market volume spike 16 Jan 2026: watch A$0.06

ByHuzaifa Zahoor January 15, 2026January 15, 2026

We see a large pre-market volume spike in RGT.AX stock on 16 Jan 2026 that lifts intraday interest. Volume at 4,495,188.00 shares is more than 52.61x the average of 85,449.00, signalling abnormal trading activity ahead of the ASX open. Price is stable at A$0.06, with a day range between A$0.059 and A$0.08, while the 50-day average sits at A$0.07318. In this pre-market note we run through the drivers, valuation context, technical levels and a short-term watchlist for traders using a volume-spike strategy.